Success Stories: A Chinese Postdoctoral Researcher in the field of Biomedical Sciences Secures NIW Approval in 3 Months with NAILG’s Expert Assistance and Premium Processing Service.
Client’s Testimonial:
“Thank you so much for your help and contribution during the long journey. Your responsibility and reliability are truly impressive and make the whole process very smooth. Thank you again for your effort and help.”
On January 24th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Biomedical Sciences (Approval Notice).
General Field: Biomedical Sciences
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: China
State of Residence at the Time of Filing: Ohio
Approval Notice Date: January 24th, 2025
Processing Time: 3 months (Premium Processing Requested)
Case Summary:
A biomedical sciences expert from China approached us for assistance with his National Interest Waiver (NIW) petition. Our team of experts carefully built a strong case, highlighting his academic and professional achievements to demonstrate his eligibility.
Armed with a Ph.D. in biomedical and veterinary sciences, our client, a postdoctoral researcher, is researching the role of immune cells in human diseases, including autoimmunity and tumors. His research aimed to develop novel immunotherapies for DIPG, identify new therapeutic targets, and improve treatments for cancer and autoimmune diseases, ultimately benefiting public health and the global economy. His ongoing research at one of the most prestigious national hospitals further advances targeted immunotherapies, as recognized by fellow experts.
One of his two recommendation letters emphasized:
“I am writing this letter to acknowledge [client's] achievements in the biomedical sciences. He has advanced the field through his expertise in investigating bovine mastitis, particularly the role of Escherichia coli (E. coli) in its progression. Specifically, [client's] research on virulence genes and antimicrobial resistance profiles is vital for developing effective mastitis management strategies for use in the dairy industry. As such, it is clear that his work is important, which informs my recommendation for his continued research in the field.”
Our team also documented his strong publication record, which includes at least 9 peer-reviewed journal articles (four first-authored) and 5 abstracts (two first-authored). His work has been cited 145 times in at least 4 highly ranked journals, demonstrating its influence in the field. Additionally, he has completed at least 18 peer reviews, a role typically reserved for esteemed researchers, further solidifying his expertise.
Furthermore, we highlighted the significance of his work by noting his research funding from the Alliance for Lupus Research (LRA), which supports advancements in treatments for lupus and other diseases in the United States.
By focusing on immunotherapy innovations, our client’s research mitigates the severity of autoimmune conditions while simultaneously facilitating more effective and personalized cancer treatments. Thus, overall, his research advances treatments for cancers and autoimmune diseases, reducing costs and improving global health and economies.
Thanks to the strength of his case, his NIW petition was approved in just under three months. We are pleased to have assisted him and wish him continued success in his career.